Background Drug-drug interaction (DDI) is a global health concern affecting patient safety and treatment outcomes. Large language models (LLMs), such as ChatGPT, offer accessible alternatives; however, their effectiveness in DDI analysis remains unclear. This review evaluates the current evidence on the performance of LLM-based chatbots in identifying DDIs.
Mondal et al. (Fri,) studied this question.